ICLR Stock Price Chart More Charts

ICLR Price/Volume Stats

ICON plc - Ordinary Shares (ICLR) Company Bio

ICON Public Limited Company provides outsourced development services to the pharmaceutical, biotechnology, and medical device industries in Ireland, rest of Europe, the United States, and internationally. The company was founded in 1990 and is based in Dublin, Ireland.

ICLR Price Forecast Based on DCF Valuation

We started the process of determining a valid price forecast for Icon Plc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Icon Plc ranked in the 26st percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Icon Plc ended up being:

• The company's debt burden, as measured by earnings divided by interest payments, is 28; that's higher than 83.86% of US stocks in the Healthcare sector that have positive free cash flow.
• The business' balance sheet suggests that 4% of the company's capital is sourced from debt; this is greater than only 13.32% of the free cash flow producing stocks we're observing.
• ICLR's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 55.65% of tickers in our DCF set.

Want more companies with a valuation profile/forecast similar to that of Icon Plc? See IQV, ABT, EHC, MTD, and COO.